EUVIMED · CrossrefZeitschrift
Current Opinion in Rheumatology
ISSN 1040-8711 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Systemic sclerosis in 2026: emerging paradigms from the World Scleroderma Congress
Genetics of vasculitis
Update on biologics in SLE
Epidemiology and outcomes of rheumatoid arthritis
Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care
Harnessing artificial intelligence to advance insights in systemic sclerosis skin and lung disease
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype
Human genetics of Whipple's disease
Evolution of the axial spondyloarthritis disease activity score and uptake in clinical practice
Nutritional guidance in spondyloarthritis: confronting the evidence gap
Pediatric antiphospholipid syndrome: expanding our understanding of antiphospholipid syndrome in children
Clinical endpoints in myositis: challenges and ways forward
A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018–2024
Investigating gout flares: beyond a definition
Disease modification in axial spondyloarthritis – still a controversy?
Autoantibodies in rheumatoid arthritis – rheumatoid factor, anticitrullinated protein antibodies and beyond
Chimeric antigen receptors: “CARs” in the fast lane for rheumatology
Epidemiology of osteoarthritis: literature update 2022–2023
Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology
The contribution of endothelial cells to tissue fibrosis
Recent developments in the synovial fibroblast pathobiology field in rheumatoid arthritis
Large language models and the future of rheumatology: assessing impact and emerging opportunities
What is PFAPA syndrome? Genetic clues about the pathogenesis
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis
Myopathy in systemic sclerosis
Inflammatory eye disease for rheumatologists
Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells
Current views on lupus in children
Inflammation in osteoarthritis: the latest progress and ongoing challenges
Low-dose interleukin-2 therapy: a promising targeted therapeutic approach for systemic lupus erythematosus
Jahrgänge
2026 · 622025 · 552024 · 792023 · 612022 · 572021 · 822020 · 852019 · 1002018 · 1032017 · 992016 · 1002015 · 922014 · 1102013 · 1142012 · 1052011 · 1072010 · 1122009 · 1052008 · 1182007 · 1042006 · 1062005 · 1052004 · 1262003 · 1132002 · 1112001 · 932000 · 961999 · 1061998 · 1071997 · 1071996 · 1081995 · 991994 · 1241993 · 1061992 · 491991 · 1411990 · 1481989 · 91
EUVIMED